The progress of AAV-mediated gene therapy in neuromuscular disorders

Expert Opinion on Biological Therapy
Sara AgutiHaiyan Zhou

Abstract

The well-defined genetic causes and monogenetic nature of many neuromuscular disorders, including Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), present gene therapy as a prominent therapeutic approach. The novel variants of adeno-associated virus (AAV) can achieve satisfactory transduction efficiency of exogenous genes through the central nervous system and body-wide in skeletal muscle. In this review, we summarize the strategies of AAV gene therapy that are currently under preclinical and clinical evaluation for the treatment of degenerative neuromuscular disorders, with a focus on diseases such as DMD and SMA. In addition to gene replacement strategy, we provide an overview of other approaches such as AAV-mediated RNA therapy and gene editing in the treatment of muscular dystrophies. AAV gene therapy has achieved striking therapeutic efficacy in clinical trials in infants with SMA. Promising results have also come from the preclinical studies in small and large animal models of DMD and several clinical trials are now on the way. This strategy shows great potential as a therapy for various neuromuscular disorders. Further studies are still required to confirm its long-term safety and improve the efficacy.

References

Jan 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·F J KoczotJ A Rose
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P L Hermonat, N Muzyczka
Jan 1, 1980·Acta Neuropathologica·F M Tomé, M Fardeau
Jul 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·G S TaylorJ E Dixon
Sep 2, 2000·The Journal of Biological Chemistry·L GormanR Kole
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·B WangX Xiao
Dec 7, 2002·Neuromuscular Disorders : NMD·Meriel McEntagartCarina Wallgren-Pettersson
Aug 13, 1965·Science·R W ATCHISONW M HAMMON
Nov 6, 2004·Science·Aurélie GoyenvalleOlivier Danos
Jul 5, 2006·Nature Medicine·Paul GregorevicJeffrey S Chamberlain
Feb 3, 2007·Proceedings of the National Academy of Sciences of the United States of America·Helge AmthorKetan Patel
Apr 12, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zejing WangRainer Storb
May 17, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julien MarquisDaniel Schümperli
Mar 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Amanda M HaidetBrian K Kaspar
Jul 31, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Guy L OdomJeffrey S Chamberlain
Oct 2, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Yongping YueDongsheng Duan
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Nov 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Louise R Rodino-KlapacLouis G Chicoine
Jan 28, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Julie DumonceauxLuis Garcia
Apr 7, 2010·Science Translational Medicine·Janaiah KotaBrian K Kaspar
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Florian SonntagJürgen A Kleinschmidt
Jun 3, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Joe N KornegayXiao Xiao
Jun 12, 2010·Science Translational Medicine·Chiara F ValoriMimoun Azzouz
Oct 12, 2010·The New England Journal of Medicine·Jerry R MendellChristopher M Walker
Dec 2, 2010·Human Molecular Genetics·Elisa DominguezMartine Barkats
Nov 10, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dawn E BowlesR Jude Samulski
Nov 17, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sebahattin CirakFrancesco Muntoni
Dec 7, 2011·The Journal of Gene Medicine·Taeyoung KooGeorge Dickson

❮ Previous
Next ❯

Citations

Jul 10, 2019·Der Nervenarzt·Afshin SaffariAndreas Ziegler
Jan 10, 2020·Human Gene Therapy·Patrizia Tornabene, Ivana Trapani
Feb 12, 2020·Nature Reviews. Genetics·Chengwen Li, R Jude Samulski
Feb 19, 2020·Disease Models & Mechanisms·Jennifer Morgan, Terence Partridge
Jul 22, 2020·Pharmacological Reports : PR·Agnieszka Łoboda, Józef Dulak
Dec 29, 2020·Journal of Inherited Metabolic Disease·Édouard BerlingAlan O'Brien
Nov 27, 2020·Journal of Neuroscience Methods·Antonio LuchicchiNathan Marchant
Jan 24, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Helena Costa VerderaFederico Mingozzi
Mar 5, 2021·Frontiers in Medicine·Brittany P FennerLyle L Moldawer
May 31, 2020·The Journal of Pediatrics·Amy G FeldmanCara L Mack
Aug 3, 2021·Journal of Neuromuscular Diseases·Jennifer Morgan, Francesco Muntoni
Aug 22, 2021·Journal of Cellular and Molecular Medicine·Kissaou T TchedreSamarendra K Mohanty
Nov 9, 2021·EMBO Molecular Medicine·Srinivasarao RepudiRami I Aqeilan

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Michael J BlankinshipJeffrey S Chamberlain
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
L M Judge, J S Chamberlain
Frontiers in Bioscience (Landmark Edition)
Rachid BenchaouirAurélie Goyenvalle
© 2022 Meta ULC. All rights reserved